Qube Research & Technologies (QRT)
RPTX

Qube Research & Technologies (QRT)’s Repare Therapeutics RPTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-299
Closed -$987 – 3983
2024
Q2 		$987 Sell
299
-679
-69% -$2.42K ﹤0.01% 3268
2024
Q1 		$4.61K Sell
978
-2,082
-68% -$13.3K ﹤0.01% 3904
2023
Q4 		$22.3K Buy
+3,060
New +$17.1K ﹤0.01% 3468
2023
Q1 		– Sell
-10,664
Closed -$157K – 2951
2022
Q4 		$157K Sell
10,664
-1,569
-13% -$23.5K ﹤0.01% 1884
2022
Q3 		$148K Sell
12,233
-3,596
-23% -$46.3K ﹤0.01% 1860
2022
Q2 		$221K Buy
+15,829
New +$186K ﹤0.01% 1692

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RPTX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Repare Therapeutics (RPTX) in Q3 2024, closing a stake of 299 shares — an estimated $987 sold.

Qube Research & Technologies (QRT) first reported a position in RPTX in Q2 2022 and held it in 6 quarters. The position peaked at $221K in Q2 2022. 56 funds tracked by Wall St. Rank hold RPTX as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Repare Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 299 Repare Therapeutics shares in Q3 2024, an estimated $987.
  • Qube Research & Technologies (QRT) first reported a position in Repare Therapeutics in Q2 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Repare Therapeutics position peaked at $221K in Q2 2022.
  • 56 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.